Co-Diagnostics, Inc. - Common Stock (CODX)

CUSIP: 189763105

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 7 signals
Share change
-76,551
Put/Call ratio
14%
SEC-reported price per share
$0.17
Indexed holders
28
Value change
-$85,846
Number of buys
12
Open additional details 1 more signal available
Number of sells
17
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
38,539,454

Security key

189763105

Report period

Q4 2025

Indexed institutions

28

Top holders

10

Ownership snapshot

Top reported holders of CODX - Co-Diagnostics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Orca Capital AG
Disclosed value leader
Orca Capital AG
Comparable rows
2/15
Latest evidence
28 Oct 2025
13D/G 13F 3/4/5 Lead comparable stake: 3.7% 13 rows are not safely comparable across share classes. 13D/G row: Orca Capital AG Showing 1-6 of 15 holder rows.

Quick read

Orca Capital AG leads the comparable SEC ownership view at 3.7%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Orca Capital AG's linked filing trail.
Comparable ownership Top 2
Orca Capital AG 3.7%
VANGUARD GROUP INC 3.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Orca Capital AG
13D/G
3.7%
Reported 13D/G · 28 Oct 2025
$818,338
2,248,182 shares
+$19,827 28 Oct 2025
VANGUARD GROUP INC
13D/G 13F
The Vanguard Group · Company
3.5%
Reported 13D/G · 30 Sep 2025
$620,967
1,705,952 shares
$0 30 Sep 2025
Private Advisory Group LLC
13F
Company
13F
—
denominator unverified
$406,482
1,181,633 shares
— 30 Sep 2025
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$298,428
867,522 shares
— 30 Sep 2025
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$147,039
427,440 shares
— 30 Sep 2025
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$110,106
319,990 shares
— 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
28
Shares
5,542,504
Indexed holders
28
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 indexed holders
33
Q4 2025 indexed holders
28
Indexed holder difference
-5
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .